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Summary 
Vitamin A serves as a prohormone from which three classes of active metabolites are derived: 
the  aldehydes,  the  carboxylic  acids,  and  the  retro-retinoids.  Although  these  three  classes  are 
united under the rubric of signal transduction, they act by different molecular mechanisms: the 
11-cis-refinaldehydes  combine with opsin to form the universal visual pigments and the retinoic 
acids form ligands for transcription factors, whereas the retro-retinoids,  as shown here, intersect 
with signal transduction at a cytoplasmic or membrane site.  The retro-retinoid,  anhydroretinol 
(AR), has long been known to act as a growth inhibitor in lymphocytes, whereas 14-hydroxy- 
4,14-retro-retinol  (14-HRR)  is required for normal lymphocyte proliferation. A  mutually re- 
versible relationship exists between these two retro-retinoids as one can reverse the effects of the 
other when given in pharmacological doses. The common explanation for reversible inhibition 
is competition for a shared receptor. We now provide evidence that when AR is given to T 
cells unmitigated by 14-HRR, rapid cell death can occur. The circumstances are closely related 
to nonclassical forms of apoptosis: within 2 h of AR administration the T  cells undergo wide- 
spread morphological changes, notably surface blebbing and ballooning and, inevitably, burst- 
ing.  In contrast, nuclear changes are comparatively mild, as indicated by absence of chromatin 
condensation and overt DNA cleavage to discrete nucleosomal fragments, although DNA nicks 
are  readily  discernible  by  terminal  deoxynucleotidyl  transferase  assay.  What  further  distin- 
guishes the AR-induced form of apoptosis from classical ones is a lack of requirements of mes- 
senger RNA and protein synthesis, suggesting that the events leading to cell death are primarily 
initiated and play themselves out in the cytoplasm. This view is further reinforced by the find- 
ing that herbimycin A can prevent the onset of programmed cell death. The importance of our 
findings is that they strongly suggest a second messenger role for vitamin A metabolites in the 
cytoplasmic realm that  has not been seen previously.  These  findings  are  entirely compatible 
with a general notion that in a cell requiring multiple coordinated signals  for survival, the pro- 
vision of an unbalanced signal can initiate programmed cell death.  Collectively, our data also 
challenge the paradigm that retinoids (outside vision) solely mediate their function via the ste- 
roid/retinoic acid receptor family of nuclear transcription factors. Instead, a mode of action in 
the cytoplasmic realm akin to one attributed to other small lipophilic second messenger mole- 
cules, such as diacyl glycerol or ceramide, may apply to retro-retinoids. 
W 
hen  resting  lymphocytes  are  stimulated  through 
their antigen receptors, they initiate a complex sys- 
tem of signal transmission  and  amplification that  employs 
several parallel,  though  coordinated,  pathways.  The  end 
result is a reprogramming of the nucleus with consequent 
structural and functional changes, initiation of proliferation 
being  one  of them.  Transformed lymphocytes proliferate 
constitutively,  but  are  as dependent  on functioning signal 
pathways as their normal counterparts. They grow because 
their signal apparatus linked to cell cycle control is perma- 
nently turned on owing to mutations in one or more com- 
ponents  (1,  2).  Most signaling pathways are unaffected by 
these mutations. 
Intracellular signal events are not only mediated by phos- 
phokinases  and  phosphatases  but  also  intersect  with  en- 
zymes that generate chemical mediators. Examples include 
small lipophilic  molecules,  such  as  diacyl glycerol (3)  and 
ceramide (4). These molecules are believed to activate me- 
diator-specific  phosphokinases  and  feed  back  into  signal 
cascades  whose  upper  portion  may  have  triggered  their 
synthesis.  Thus,  these  lipophilic  second  messenger mole- 
cules may serve as amplification devices. 
The metabolites of vitamin A  (retinol, Fig.  1, structure  1) 
belong to  the  family of lipophilic  mediators.  The  widely 
studied  metabolite,  retinoic  acid  (Fig.  1,  structure  2),  has 
been linked  to  differentiation in  different cellular systems 
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binding ofretinoic acid to specific nuclear receptors on the 
promoters of pertinent genes (8, 9). Retinoic acid action is 
thus related to that of steroids and thyroid hormone. How- 
ever, control of differentiation is only one of the functions 
carried out by vitamin A, in addition to its role in vision. 
lLetinol is also involved in controlling proliferation in sev- 
eral  cellular  systems  (10-13).  Interestingly,  retinoic  acid 
does not substitute for retinol in the cell growth assay. In- 
stead,  other  metabolites appear  to  be  used  in  the  role  of 
regulator of cell growth, as described for mitogen-activated 
normal  and  transformed  lymphocytes  (12).  The  growth 
regulatory function  has  been  traced  to  14-hydroxy-4,14- 
retro-retinol (14-HP,  IL  I, Fig. 1, structure  3)  (11,  14). 
That  14-HlLlL,  like  retinoic  acid,  appears  to  engage  a 
cellular receptor followed from pharmacological studies with 
the  naturally  occurring  structural  analog,  anhydroretinol 
(AR., Fig. 1, structure  4). AlL inhibits the growth-promoting 
activity of 14-HRlL,  and  this  negative  effect  can  be  re- 
versed by increased doses of 14-HlLR (15,  16). Eventually, 
however, given high enough doses, AP, displaces 14-HlLlL 
completely  and  initiates  a  signal  that  leads  to  rapid  cell 
death.  Based on the paradigm of reversible inhibition, the 
best assumption is that  14-HP,  lL and AP. bind to the same 
receptor,  neither  the  location nor  the  nature  of which  is 
presently known,  although explanations involving multiple 
receptors are possible. By  analogy with  retinoic  acid  one 
might imagine a  nuclear receptor,  but  on  the basis of the 
findings  presented  below,  this  may  not  be  so.  We  show 
that  the cell death signal triggered by AIL is not mediated 
by induced  lLNA transcription  and  protein synthesis, but 
involves  a  signaling step  leading to  catastrophic  morpho- 
logical changes  and  damage  to  DNA  akin  to  nonclassical 
apoptosis. We conclude that the action of AR, unmitigated 
by its positively acting counterpart,  14-HlLR,  can induce 
programmed cell death. Furthermore, by inference the pu- 
tative  receptor  for  14-HR.R/AlL  may  be  cytoplasmic  or 
cell membrane  associated, and therefore the paradigm that 
retinoids  outside  vision  mediate  their  function  solely via 
ligand-assisted transcription may have to be amended. 
Materials  and Methods 
Cell Lines.  The nmrine T  cell line, ERLD, was derived from 
a thymoma of C57B1 mice at Sloan-Kettering Institute (17). The 
Epstein-Barr virus-transformed human B lymphoblastoid cell 5/2 
was established from the blood of a healthy volunteer. Both cell lines 
were  serially passaged  in  RPMI-1640  medium  supplemented 
with 7% fetal calf serum and antibiotics. 
Reagents.  Herbimycin  A,  methyl  2,5-dihydroxycinnamate, 
lavendustin A,  staurosporin, genistein,  actinomycin D,  all-tram 
retinol, and cycloheximide were purchased from Sigma Chemical 
1Abbreviations used in  this paper: AlL, anhydroretinol; b-dUTP, biotiny- 
lated dUTP;  EILLI), E-strain, radiation-induced leukemia 1);  |4-HI<R., 
14-hydroxy-4,14-retro-retinol; JTLB,  insulin, transferrin, linoleic acid, 
and bovine albumin medium. 
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Figure 1.  Structures. 
Co. (St. Louis, MO). and stored as concentrated stock solutions at 
-70~ 
Retinoids.  t4-HRR  and  AR  were  synthesized  as  reported 
(14,  16). Both retinoids were purified by reversed phase HPLC 
and stored as methanolic solution under argon at -70~ 
Cell Culture Experiments.  ERLD or 5/2 cells were transferred 
to serum-free insulin, transferrrin, linoleic acid, and bovine albu- 
min (ITLB) medium (2) and plated in microtiter plates with the 
drugs and retinoids as specified in the figure legends. At the indi- 
cated time points, cell samples were counted in the presence of 
trypan blue under an inverted microscope. The close spacing of 
time  points  with  multiple parallel cultures  precluded  counting 
replicate cultures.  However,  each  expermmnt  was  repeated  at 
least three times and yielded the same basic data. 
TdT Assay for DNA Damage.  Measurement of 1)NA nicking 
was performed with minor modifications according to Gorczyca 
et al. (18), vie., incorporation ofbiotinylated-dUTP (b-dUTP) at 
free 3' OH ends of nicked DNA by TdT followed by FITC-avi- 
din  staining.  Log-phase EP, LD  murine  T  leukemia cells  were 
preincubated with actinomycin D, cyclohexinfide, or herbimycin 
A, and subsequently treated with varying concentrations ofretin- 
oids as indicated in the legend to Fig. 4 B. At specified time inter- 
vals, aliquots of cell samples were collected and fixed in 1% form- 
aldehyde/PBS/0.1%  Triton  X-100  on  ice,  washed  once  with 
PBS,  resuspended in cold 70%  ethanot/PBS,  and stored at 4~ 
After rehydration, cells were resuspended in cacodylate buffer, 25 
mM COC12, and 0.5 nmol b-dUTP in the presence or absence of 
10 U  TdT enzyme (Boehringer Mannheim Biochenficals, India- 
napolis, IN). After a PBS wash,  cells were resuspended in FITC- 
avidin staining buffer containing 4￿  SSC, 2.5  btg/ml FITC-avi- 
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Inhibition ofAR-induced cytotoxicity by 14-HRR. ERLD 
cells were simultaneously  treated with different concentrations of AR and 
serially diluted 14-HRR. Ratios of live and dead cells were determined 
after 4 h of culture by trypan blue exclusion. 
din  (Boehringer Mannheim  Biochemicals), 0.1%  Triton X-100 
(Sigma Chemical Co.) and 5% non-fat dry milk. After a 30-min 
incubation in  the  dark,  cells  were  washed in  PBS/0.1%  Triton 
X-100 and resuspended in PBS containing 5  ~g/ml propidium 
iodide, 0.1%  RNase A  (Sigma Chemical Co.)  and 0.1%  Triton 
X-100. DNA content vs. dUTP incorporation of individual cells 
(~20,000  gated events per sample)  was  measured by respective 
red and green fluorescence on a FACScan|  flow cytometer using 
Celquest data analysis  (both from Becton Dickinson & Co., San 
Jose,  CA)  and  Multicycle statistical analysis  software  (Phoenix 
Flow Systems, San Diego, CA). 
Results 
We have previously reported that 14-HlLlL and AR dis- 
play a mutually antagonistic relationship in regard to regu- 
lation of the growth of human lymphoblastoid cells and re- 
ceptor-mediated  activation  of murine  T  cells  (15).  We 
showed  that  the  entire  dose-response curves  of 14-HRR 
could be shifted to higher concentration ranges by simulta- 
neously increasing the concentration of added AR. We in- 
terpreted  these  results  of reversible inhibition as  evidence 
for a common receptor for which these two retinoids com- 
pete.  The  T  cell line,  ERLD,  and  the  lymphoblastoid B 
cell line, 5/2,  are exquisitely sensitive to AlL. At a concen- 
tration range of 6  X  106 M  to 6  ￿  10 -7 M, this drug led to 
rapid cell death (Fig. 2). AlL acted presumably by overrid- 
ing  the  endogenous  retinol  metabolite,  14-HRR.  Cyto- 
toxicity was reversible by 14-HRR  (shown with ERLD in 
Fig. 2)  or its precursor, retinol (data not shown).  Retinoic 
acid  was  inert  in  this  assay  system,  neither  inducing  nor 
preventing cell death  (data not shown).  Therefore,  the re- 
versible  inhibition  observed  previously  in  the  long-term 
tissue culture experiments with normal T,  lymphoblastoid 
5/2, and promyelocytic HL-60 cells (13,  15) also holds true 
in the newly developed short-term culture system. 
AIL-induced cell death was not distinguishable from the 
cell cycle-independent cell death  we  previously described 
consequent  to  retinol  deficiency  (19).  In  either  case,  the 
cells showed a disintegrating cytoplasm with fused vacuoles 
whereas the nuclei, with their nucleoli, remained intact for 
prolonged periods of time. AR  administration appeared to 
accelerate this process in strict dose dependency,  inducing 
at the maximum dose used widespread surface blebbing, bal- 
looning, and osmotic bursting of cells within 2-4 h  (Fig. 3). 
However, neither the degradation of DNA to oligonucleo- 
somal  bands  (Fig.  4  A)  nor  the  chromatin  condensation 
typical for  apoptosis  (not  shown)  was  evident.  Neverthe- 
less, as a result of exposure to AR, the DNA was damaged, 
displaying multiple nicks that  were  detected by the  sensi- 
tive TdT reaction (Fig. 4  B). Importantly, however, micro- 
scopic inspection  in  the  presence  of the  vital dye,  trypan 
blue, revealed that the widespread cellular swelling and os- 
motic  damage  occurred  simultaneous  to  or  even  before 
DNA damage. 
That  14-HRR  and  retinol  rescued  cells  from  AR- 
induced  cytotoxicity (Fig.  2)  argued  against  trivial mem- 
brane  toxicity.  Furthermore,  the  rapid  onset  of  cellular 
damage made  a  nuclear mechanism unlikely, as the  1-2-h 
time span from the administration of AR to the appearance 
of cytosolic cell swelling would be relatively short for a sig- 
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Figure 3.  Morphological changes associated  with 
AR-induced cytotoxicity.  ERLD  cells were  cul- 
tured in the presence of 2 ￿  10  -6 M anhydroret- 
inol. At the onset of culture, scanning electron mi- 
crographs revealed  the  normal  appearance with 
numerous surface ruffles (le~). 3 h later, most cells 
had lost their ruffled appearance, exhibited numer- 
ous blebs, looked bloated, in part took on a cra- 
tered  appearance, and  began  to  leak  amorphous 
material (n],4ht).  By trypan blue uptake, most cells 
were no longer osmotically intact. Figure 4.  (A) Absence of DNA fragmentation in AR-induced apoptosis. ERLD cells were cultured in the absence (lane 1) or presence (lanes 2-.5) of 
10  {' MAR. Regardless of treatment modality of time, the integrity of DNA was completely preserved, although at the 3- and 6-h time points (lanes 4 
and 5), most cells  were dead by trypan blue exclusion. (B) TdT assay  for DNA damage. In rapidly proliferating ERLD murine T leukemia cells,  induction 
ofapoptosis in cumulative effect is measured by TdT incorporation of  biotin-labeled dUTP/FITC-avidin at 3' OH termini of nicked 1)NA. Cell samples 
were preincubated with actinomycin D (3 btg/ml), cycloheximide (10 p.g/ml), herbimycin A (2 p,g/ml), or ITLB medium alone. Preincubated and ad- 
ditional test samples  were then supplemented with retinoids, AR or 14-HRR, at the concentrations shown. Aliquots were collected at time intervals of 
2, 4, 8 (shown here), or 24 h. Cells were fixed, stained, and assayed  for DNA content vs. dUTP incorporation by red/~een fluorescence measurement 
by flow cytometry as described in Materials  and Methods. 
nal  to  be  initiated in  the  nucleus,  exported  to  the  cyto- 
plasm,  and  implemented  there.  Retinoids,  on  the  other 
hand,  have  been  squarely tied to  a  nuclear  mechanism  of 
action,  obeying the  paradigm  of ligand-assisted transcrip- 
tional activation (20, 21). Whereas retro-retinoids  have been 
tested for their ability to  act as ligands for RARs,  RXRs, 
and orphan receptors, none has so far shown  any transacti- 
vation  of direct  binding  activity  (Buck,  J.,  R.  Evans,  U. 
H~mmerling,  D.  Mangelsdor~  F.  Derguini,  and  R.  Hey- 
man,  unpublished  results). To  clarify whether  or not new 
RNA  transcription and protein synthesis were required for 
the induction of cytotoxicity, ERLD  cells were  pretreated 
with actinomycin D  or cycloheximide before AR was ap- 
plied. Neither  drug showed  any sign of inhibition of AR- 
induced cytotoxicity (Fig. 5, A  and B), although actinomy- 
cin  D  inhibited the  AR-induced DNA  damage  observed 
in  the  TdT  assay  (Fig.  4  /3).  Indeed,  not  surprisingly, 
cycloheximide at doses  >1  p~g/ml slightly accelerated cell 
damage inflicted by AR, as well as causing moderate apop- 
totic damage on its own (Fig. 4  B). Evidently then, macro- 
molecular synthesis was of secondary importance,  and  the 
main  events  appeared  to  be  confined  to  the  cytoplasm. 
These considerations brought up the question of how ale- 
thal  signal could be  delivered, if indeed signaling was  in- 
volved  at  all.  Since  our  previous  work  had  shown  14- 
HRR  to be a  contributing factor in T  cell activation (12), 
we  decided  to  test  different  pharmacological  blockers  of 
signal  transduction.  Staurosporin,  an  inhibitor  of protein 
kinase  C  (22),  and  the  tyrosine  kinase  inhibitors,  methyl 
2,5-dihydroxycinnamate, lavendustin A, and genistein (23), 
were inert in the assay system used (data not shown). How- 
ever,  herbimycin A,  a  putative  inhibitor of src-like  phos- 
photyrosine kinases, prevented AR-induced cell death (Fig. 
6). During the observation period of 8  h,  herbimycin A  at 
3  and  1 p.g/ml was able to efficiently, and at 0.3  p~g/ml to 
partially, suppress the AR effect. 
Discussion 
Of the three classes of retinol metabolites, i.e., the alde- 
hydes, the carboxylic acids (all trans and 9-cis retinoic acids), 
and the retro-retinoids  (11),  the mechanisms of action have 
been delineated with certainty for the first two.  In the first 
class, 11-cis-retinaldehyde combines with opsin to form the 
universal  visual  pigment.  Excitation  by  light  triggers  the 
phototransduction  cascade  that  ultimately  leads  to  de- 
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Figure 5.  Failure  of actinomycin D (.4) and cycloheximide (B) to in- 
hibit AR-induced cell death. EtkLD cells  were incubated for 30 rain with 
indicated doses ofactinomycin D (A) or cycloheximide (/3) and then cul- 
tured with the different concentrations of AP.. 4 h later, differential cell 
counts were performed in trypan blue. I, AlL 6 ￿  10  ~ M; [], AR 2 X 
10  r  AR6 ￿  I0  -T M; ~], none. 
creased channel  conductivity and a  nerve impulse.  This is 
an  example, par excellence, of inside-out signal transduc- 
tion. In the second class, retinoic acids mediate signals from 
the  extracellular environment  to  the transcripitional appa- 
ratus by direct passage into the nucleus and binding to the 
preexisting nuclear receptors.  In the third class, retro-retin- 
oids, 14-HRR,  and AR are also implicated in signal trans- 
duction,  although  their receptors are  not  known.  Opera- 
tionally, they belong to the group of small lipophilic second 
messenger  molecules,  since  they  are  synthesized  in  the 
same cell that they purportedly regulate (irrespective of the 
fact  that  because  they  can  easily  traverse  biomembranes 
they might  also operate in paracrine fashion).  14-HlLR  is 
widely distributed in the body, and it appears that virtually 
all dividing cells synthesize this metabolite. The analysis of 
a panel of tissue culture cell lines representative of a  wide 
variety of tissues has revealed none that was unable to me- 
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Figure  6.  Inhibition  of AR-induced cell  death  by  herbimycin  A. 
ERLD cells were cultured with 2 X 10 -6 M AR and the indicated con- 
centration of herbimycin A. Dead/live ratios were followed over time by 
differential  counting in trypan blue. 
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tabolize tritiated retinol to 14-HILIL (O'Connell, MJ., and 
U. HSmmerling, unpublished results). Moreover, 14-HRR 
is evolutionarily conserved from insects to humans.  Func- 
tionally, it has been consistently linked to cell proliferation 
(12),  as  14-HR.R  has proven  to  be  of critical importance 
for activation of resting normal ceils and for maintenance of 
cycling cells in  a  number  of cases.  The  best evidence for 
this is  the  ability of 14-HKK  at physiological concentra- 
tions to reverse the cell cycle arrest brought on by vitamin 
A  withdrawal in several cell lines. Retinoic acid is inactive 
in  that  respect.  How  this  growth  regulation  may  be  ef- 
fected, what molecular targets may be involved, and espe- 
cially what might be the nature of the primary receptor(s), 
are unclear.  That  there is a  receptor can be inferred from 
pharmacological studies of an antagonist of 14-HRK,  AR 
(15,  16). We have shown previously that the growth-pro- 
moting activity of 14-HRR  can be completely and revers- 
ibly inhibited by AlL, strongly suggesting competition of 
binding to the same molecule. Other explanations are con- 
ceivable in which two independent receptors are invoked, 
necessitating convergence of compensating signal pathways 
at some downstream point. 
In  our  experiments  we  have  used  cell  death  or  DNA 
damage induced by AIL as biological readouts. E1LLD  is a 
cell line  derived from  a  murine  T  cell lymphoma  that  is 
fortuitously of exceptional sensitivity to AR. This is by no 
means unusual as many cell lines of murine or human ori- 
gin react to AR with a gradation of consequences, ranging 
from growth retardation to full arrest and frequently to cell 
death. As vitamin A  starvation in these same cells produces 
similar symptoms of growth arrest and cell death, although 
by slower kinetics, it is possible that the critical issue is the 
availability of 14-HRR.  If so, the action of exogenous AR 
may be  to  antagonize  the  endogenous  14-HlLlL, whereas 
in  retinol starvation,  14-HRR  synthesis may be  gradually 
curtailed for lack  of biochemical precursor.  This  concept 
has  been  tested previously in  vitamin A-deprived HL-60 
cells where cell viability was found to be sustained as long 
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14-HRR  biosynthesis  and  preservation  of a  constant  14- 
HRR  level.  The  eventual  exhaustion  of this  intracellular 
store of vitamin A  coincided precisely with a decline of the 
intracellular  14-HRR  concentration,  loss of cell prolifera- 
tion,  and cell death (13). 
The important  question  is whether AR,  unmitigated  by 
14-HRR,  activates programmed cell death.  Several obser- 
vations  indicate  that  this  may  be  the  case.  Foremost  are 
morphological  changes,  including  surface  blebbing  and 
widespread  osmotic  damage  (Fig.  3).  Second,  the  data  in 
Fig.  4  indicate  that nicks  in the  DNA  abound  after expo- 
sure to AR.  These symptoms are commonly interpreted  as 
signs  of apoptosis.  Yet  we  have  not  observed  two  other 
manifestations of classical apoptosis: there was neither chro- 
matin  condensation  nor  nucleosomal  fragmentation  of 
DNA  (Fig.  4  A).  Rather,  the  overall picture  fits more the 
nonclassical apoptosis associated with perforin-induced  cy- 
totoxicity (24, 25). 
The  reaction  of ERLD  cells to  AR  is  among the  most 
fulminant ones seen to date,  and the short time span of only 
1-2  h,  in  which  morphological  changes  such  as  surface 
blebbing,  ballooning,  and  eventually  cell  rupture  occur, 
alerted us to the possibility that the sequence of events was 
mostly cytoplasmic.  Importantly,  the  morphological  dam- 
age seemed to occur with the same kinetics as DNA  dam- 
age,  yet  did  not  depend  on  RNA  and  protein  synthesis 
(Fig.  5), implying a cycle of events triggered mainly in the 
cytoplasm and perhaps not stemming from nuclear damage. 
In fact, there is no compelling reason to think that nuclear 
damage spotted  by the  TUNEL  technique  is the  cause  of 
cell  death,  in  particular  since  the  fate  of cells  was  sealed 
whether transcription  or translation  was active or not.  The 
observed  DNA  damage  could  be  ancillary  to,  or  even  a 
consequence  of, a catastrophic  event triggered in the cyto- 
plasm by a pharmacological dose of AR. 
Assuming that retro-retinoids act as second messengers,  a 
precedent for the induction  ofapoptosis by small lipophilic 
messengers exists. It has been reported that ceramide, when 
given to  cells as the  sole stimulator,  can induce  cell  death 
by apoptosis. The pertinent point is that ceramide is known 
to regulate certain phosphokinases  (4), and by analogy, the 
14-HRR/AR  pair of agonists/antagonists  may do so, too. 
The reversal of AR effects by herbimycin A  is also consis- 
tent with  the notion  that AR is involved in signaling,  act- 
ing perhaps  as a  second  messenger.  Herbimycin A  can  re- 
verse the  transformation  by the  oncogenes  src, fps,  and  abl 
but is not effective against the transformation by ras, raf and 
myc (26).  It also  inhibits  signal  transduction  by the  T  cell 
antigen  receptor  (27).  Contrary  to  lavendustin  A  and 
genistein, herbimycin A does not bind to the ATP-binding 
domain of tyrosine kinases but reportedly inhibits the asso- 
ciation  of p60 v-src with  the  cytoskeletal structure  and  with 
phosphatidylinositol  3'-kinase  and  may exert  its  effect  on 
SH2 functions  (28). Recently,  it was shown that herbimy- 
cin A  can induce  apoptosis in  several cellular systems  (29, 
30)  possibly  by  preventing  the  upregulation  of  bcl-2 
mRNA.  It is striking  that  one  and  the  same  drug  can  in 
one  context  prevent  cell death  induced  by AR,  as  shown 
here, and in another induce apoptosis. 
Although  the  regulatory  circuits  negatively  affected  by 
AR  and  resulting  in  lethality  may  not  be  identical  with 
those  functioning  in growth  regulation,  they appear to be 
connected  with  the  same receptor.  This  follows  from  the 
ability of 14-HRR  to reversibly block the lethality induced 
by AR  (Fig.  2),  exactly as  reported  previously for growth 
regulation.  Hence, we can assume that the cell death signal 
is initiated by AR at a similar site as the growth signal trans- 
mitted  by  14-HRR,  although  the  resulting  cascades  di- 
verge and  lead to  totally different  events.  Besides  demon- 
strating the  involvement  of vitamin A  in the  regulation  of 
cell vitality, our results speak also to the issue of its mecha- 
nism of action. Although this is frequently equated with re- 
tinoic  acid,  the  events  described  here  are  clearly  separate 
from those mediated by retinoic  acid.  They involve differ- 
ent  vitamin  A  metabolites,  the  retro-retinoids,  and,  inas- 
much as they appear to be located in the cytoplasmic realm 
and not the nucleus,  different receptor molecules.  To reca- 
pitulate,  two  criteria support our conclusion  that the AR/ 
14-HRR  receptors are cytoplasmic, viz., AR-induced  cell 
death is independent  of macromolecular synthesis, i.e.,  cy- 
totoxicity incurred  by AR is insensitive  to actinomycin D 
and  cycloheximide,  and  DNA  damage  induced  by AR  is 
inhibitable  by herbimycin A. This is an important  conclu- 
sion as, to date, retinol action has only been seen in the nu- 
cleus, by activation of RAR  or RXR  receptors with retin- 
oic acid, leading to increased transcription.  The mechanism 
of action  of retro-retinoids  is therefore  very likely different 
from  the  transcriptional  regulation  attributed  to  retinoic 
acid. 
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